Inhibition of 13-cis retinoic acid-induced gene expression of reactive-resistance genes by thalidomide in glioblastoma tumours in vivo
about
Thalidomide and lenalidomide for recurrent ovarian cancer: A systematic review of the literature.Comprehensive molecular biomarker identification in breast cancer brain metastases.Thalidomide inhibits proliferation and epithelial-mesenchymal transition by modulating CD133 expression in pancreatic cancer cells.
P2860
Inhibition of 13-cis retinoic acid-induced gene expression of reactive-resistance genes by thalidomide in glioblastoma tumours in vivo
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Inhibition of 13-cis retinoic ...... n glioblastoma tumours in vivo
@ast
Inhibition of 13-cis retinoic ...... n glioblastoma tumours in vivo
@en
type
label
Inhibition of 13-cis retinoic ...... n glioblastoma tumours in vivo
@ast
Inhibition of 13-cis retinoic ...... n glioblastoma tumours in vivo
@en
prefLabel
Inhibition of 13-cis retinoic ...... n glioblastoma tumours in vivo
@ast
Inhibition of 13-cis retinoic ...... n glioblastoma tumours in vivo
@en
P2093
P2860
P356
P1433
P1476
Inhibition of 13-cis retinoic ...... n glioblastoma tumours in vivo
@en
P2093
Anca-L Grosu
Carsten Sticht
Dusan Milanovic
Manuel Röhrich
Patrick Maier
P2860
P304
28938-28948
P356
10.18632/ONCOTARGET.4727
P407
P577
2015-07-30T00:00:00Z